2024 SNMMI and SNMMI-TS Grants and Awards Recipients

2024 Grants and Awards Recipients (funded by SNMMI)

Minoshima-Pappas Transformative Leadership Award - Richard Wahl, MD, FACR, FACNM, FSNMMI

Lalita and Mathew (Madhukar) Thakur Award

2024 Grants and Awards Recipients (funded by SNMMI-TS)

SNMMI-TS Outstanding Technologist

Kathy Thompson Hunt Outstanding Educator Award - 

2024 Grants and Awards Recipients (funded by WINM)

Women in Nuclear Medicine Rising Star Award- 

Women in Nuclear Medicine She Paved the Way Lifetime Achievement Award 

2024 Grants and Awards Recipient (funded by the ARRT)

SNMMI-TS Career Advancement Award - 

2024 Grants and Awards Recipients (funded by the Nihon Medi-Physics)

2024-2026 Wagner-Torizuka Fellowship Program - Hidesato Fujito, MD; Koichiro Kimura, MD; Tomoaki Otani, MD, PhD

2024 Grant Recipients (funded by the SNMMI Value Initiative)

Medical and Science Student Research GrantAditya Misra, Anuja Konda, Bella Salerno, Fardeen Ahmed, Luke Polson, Narjes, Hajimollaheydar, Suya Li, Uttkarsh Chaurasia, Vishnu Murthy

2024 Grants and Awards Recipients (funded by the PDEF)

PDEF Mickey Williams Minority ScholarshipMike No and Justin Flores

PDEF Professional Development ScholarshipChristopher Owens, CNMT, PET

PDEF Travel Awards

2024 Council and Center Awards

Saul Hertz AwardMichael Hofman, MBBS

Peter E. Valk, MD Memorial Lecuteship AwardFarrokh Dehdashti, MD, FSNMMI

GCNMC Lifetime Achievement AwardBennett Greenspan, MD, FACNM, FSNMMI

GCNMC Lectureship AwardTim Van den Wyngaert, MD, PhD

CIC Barry Siegel Lectureship AwardSteven Rowe, MD, PhD

Tracey Lynn Faber AwardElena Marie Zannoni, PhD

Edward Hoffman Lecture AwardJinyi Qi, PhD

Kuhl Lassen Award - Gitte M. Knudsen, Md, PdD

Berson-Yalow Award 

Hermann Blumgart AwardVenkatesh L. Murthy, MD, PhD

CVC Outstanding Educator AwardMouaz Al-Mallah, MD

AC Tom Miller Memorial Lectureship Award - n/a 2024

AC Distinguished Service Award - n/a 2024

AC Lifetime Achievement Award

PIC Conway-Treves Award - n/a 2024

Sally W. Schwarz Award - Stephen Dragotakes, BS, RPh, BCNP, FAPhA

CMIIT Laboratory Professional Recognition Award for Contributions to Molecular Imaging -

 

2024 Grants and Awards Recipients (funded by the ERF)

Sam Gambhir, MD Trailblazer Award - Michael Evans, PhD

Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety -

Michael J. Welch Award - Suzanne E. Lapi, PhD

Michael J. Welch Postdoctoral Grant - Yang Su

Mitzi & William Blahd, MD, Pilot Research Grant - Elena Marie Zannoni, PhD

Robert E. Henkin, MD, Government Relations Fellowship - Joseph Steiner, PhD

Ursula Mary-Kocemba Slosky, PhD, Professional Relations Fellowship - 

ERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty - n/a 2024

ERF SNMMI Postdoctoral Molecular Imaging Scholar Program - n/a 2024

Bradley-Alavi Student FellowshipsPratheek Reddy and Zekun Li

Paul C. Aebersold, PhD AwardGeorge Sgouros, PhD

The Sipra and Gopal Saha Scholarship - Zachary Olson

Alavi-Mandell Awards Published in 2023 - 

225Ac-MACROPATATE: A Novel a-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

Paden King, Nicholas T. Gutsche, Natarajan Raju, Stanley Fayn, Kwamena E. Baidoo, Meghan M. Bell, Colleen S. Olkowski, Rolf E. Swenson, Frank I. Lin, Samira M. Sadowski, Stephen S. Adler, Nikki A. Thiele, Justin J. Wilson, Peter L. Choyke, and Freddy E. Escorcia

Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

J Nucl Med 2023; 64:549–554

Evaluation of [68Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space

Aleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, Yan Li, Manuel Weber, Wolfgang P. Fendler, Julian Kirchner, Philipp Damman, Karsten Wrede, Lazaros Lazaridis, Martin Glas, Maja Guberina, Anja Eckstein, Tobias Blau, Ken Herrmann, Lale Umutlu, Michael Forsting, Cornelius Deuschl, and Benedikt Schaarschmidt

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Düsseldorf, Germany

J Nucl Med 2023; 64:1185–1190

Membrane and Nuclear Absorbed Doses from 177Lu and 161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study

Alexandre Larouze, Mario Alcocer-Ávila, Clément Morgat, Christophe Champion, and Elif Hindié

Université de Bordeaux–CNRS-CEA, Centre Lasers Intenses et Applications, UMR 5107, Talence, France

J Nucl Med 2023; 64:1619–1624

Human Epidermal Growth Factor Receptor 2–Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer

Ali Alhuseinalkhudhur, Henrik Lindman, Per Liss, Tora Sundin, Fredrik Y. Frejd, Johan Hartman, Victor Iyer, Joachim Feldwisch, Mark Lubberink, Caroline Rönnlund, Vladimir Tolmachev, Irina Velikyan, and Jens Sörensen

Division of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

J Nucl Med 2023; 64:1364–1370

177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers

Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, and Isabel Rauscher

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany

J Nucl Med 2023; 64:402–409

The Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy

Amir Karimzadeh, Matthias Heck, Robert Tauber, Esteban Solaris, Stephan Nekolla, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, and Isabel Rauscher

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany

J Nucl Med 2023; 64:1252–1258

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T

Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, and Isabel Rauscher

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany

J Nucl Med 2023; 64:1765–1771

68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer

Anouk C. de Jong, Marcel Segbers, Sui Wai Ling, Laura H. Graven, Niven Mehra, Paul Hamberg, Tessa Brabander, Ronald de Wit, and Astrid A.M. van der Veldt

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

J Nucl Med 2023; 64:1556–1562

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Arthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernandez-Arias, Nesrine Rahmouni, Firoza Z. Lussier, Marie Vermeiren, Gleb Bezgin, Paolo Vitali, Kok Pin Ng, Eduardo R. Zimmer, Marie-Christine Guiot, Tharick A. Pascoal, Serge Gauthier, and Pedro Rosa-Neto

Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada

J Nucl Med 2023; 64:1171–1178

Diagnostic Accuracy of 99mTc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses

Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa R. Schmidt, Robert S. Figenshau, Farrokh Dehdashti, and Richard L. Wahl

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

J Nucl Med 2023; 64:90–95

Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing 99mTc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience

Ashwin Singh Parihar, Lisa R. Schmidt, John Crandall, Farrokh Dehdashti, and Richard L. Wahl

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

J Nucl Med 2023; 64:485–490

Multimodality Imaging of Aortic Valve Calcification and Function in a Murine Model of Calcific Aortic Valve Disease and Bicuspid Aortic Valve

Azmi A. Ahmad, Mean Ghim, Jakub Toczek, Afarin Neishabouri, Devi Ojha, Zhengxing Zhang, Kiran Gona, Muhammad Zawwad Raza, Jae-Joon Jung, Gunjan Kukreja, Jiasheng Zhang, Nicole Guerrera, Chi Liu, and Mehran M. Sadeghi

Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, and Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut

J Nucl Med 2023; 64:1487–1494

Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study

Babs G. Sibinga Mulder, Marjory Koller, Evelien W. Duiker, Arantza Farina Sarasqueta, Jakobus Burggraaf, Vincent E. de Meijer, Alexander L. Vahrmeijer, Frederik J.H. Hoogwater, Bert A. Bonsing, Gooitzen M. van Dam, J. Sven D. Mieog, and Bobby K. Pranger

Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands

J Nucl Med 2023; 64:82–89

Ambient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via the pH Low-Insertion Peptide Conjugated to Indocyanine Green

Benedict Edward Mc Larney, Mijin Kim, Sheryl Roberts, Magdalena Skubal, Hsiao-Ting Hsu, Anuja Ogirala, Edwin C. Pratt, Naga Vara Kishore Pillarsetty, Daniel A. Heller, Jason S. Lewis, and Jan Grimm

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2023; 64:1647–1653

PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study

Caner Civan, Stefan Kasper, Christoph Berliner, Pedro Fragoso-Costa, Viktor Grünwald, Michael Pogorzelski, Benedikt Michael Schaarschmidt, Stephan Lang, David Kersting, Michael Nader, Katharina Lückerath, Ken Herrmann, Wolfgang P. Fendler, and Manuel Weber

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

J Nucl Med 2023; 64:372–378

Evaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy

Cassis Varlow and Neil Vasdev

Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada

J Nucl Med 2023; 64:460–465

Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer

Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik, and Magnus Dahlbom

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

J Nucl Med 2023; 64:1772–1778

The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions

Cécile Tissot, Stijn Servaes, Firoza Z. Lussier, João Pedro Ferrari-Souza, Joseph Therriault, Pâmela C.L. Ferreira, Gleb Bezgin, Bruna Bellaver, Douglas Teixeira Leffa, Sulantha S. Mathotaarachchi, Mira Chamoun, Jenna Stevenson, Nesrine Rahmouni, Min Su Kang, Vanessa Pallen, Nina Margherita-Poltronetti, Yi-Ting Wang, Jaime Fernandez-Arias, Andrea L. Benedet, Eduardo R. Zimmer, Jean-Paul Soucy, Dana L. Tudorascu, Annie D. Cohen, Madeleine Sharp, Serge Gauthier, Gassan Massarweh, Brian Lopresti, William E. Klunk, Suzanne L. Baker, Victor L. Villemagne, Pedro Rosa-Neto, and Tharick A. Pascoal

McGill University, Montreal, Quebec, Canada

J Nucl Med 2023; 64:452–459

Early-Phase 18F-Florbetapir and 18F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting

Cecilia Boccalini, Débora Elisa Peretti, Federica Ribaldi, Max Scheffler, Sara Stampacchia, Szymon Tomczyk, Cristelle Rodriguez, Marie-Louise Montandon, Sven Haller, Panteleimon Giannakopoulos, Giovanni B. Frisoni, Daniela Perani, and Valentina Garibotto

Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland

J Nucl Med 2023; 64:266–273

Single-Time-Point Imaging for Dosimetry After [177Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection

Chang Wang, Avery B. Peterson, Ka Kit Wong, Molly E. Roseland, Matthew J. Schipper, and Yuni K. Dewaraja

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan

J Nucl Med 2023; 64:1463–1470

161Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of 161Tb into the Clinic

Chiara Favaretto, Pascal V. Grundler, Zeynep Talip, Stefan Landolt, Lebogang Sepini, Ulli Köster, Cristina Müller, Roger Schibli, Susanne Geistlich, and Nicholas P. van der Meulen

Center for Radiopharmaceutical Sciences, ETH–Paul Scherrer Institute, Villigen-PSI, Switzerland

J Nucl Med 2023; 64:1138–1144

18F-FDG PET/CT in the Management of Osteosarcoma

Chiwoo Oh, Michael W. Bishop, Steve Y. Cho, Hyung-Jun Im, and Barry L. Shulkin

Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea

J Nucl Med 2023; 64:842–851

An Analysis of the Distribution of PSMA PET/CT–Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients

Christian Trapp, Dmytro Oliinyk, Paul Rogowski, Rieke von Bestenbostel, Ute Ganswindt, Minglun Li, Chukwuka Eze, Peter Bartenstein, Leonie Beyer, Harun Ilhan, Gabriel Sheikh, Lena Unterrainer, Christian Stief, Thilo Westhofen, Wolfgang G. Kunz, Marcus Unterrainer, Claus Belka, and Nina-Sophie Schmidt-Hegemann

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany

J Nucl Med 2023; 64:918–923

Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma

Christina Laschinsky, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P. Fendler, and Manuel Weber

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

J Nucl Med 2023; 64:1865–1868

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy

Clara Diaz Garcia-Prada, Léna Carmes, Salima Atis, Ali Parach, Alejandro Bertolet, Marta Jarlier, Sophie Poty, Daniel Suarez Garcia, Wook-Geun Shin, Stanislas Du Manoir, Jan Schuemann, Olivier Tillement, François Lux, Julie Constanzo, and Jean-Pierre Pouget

Institut de Recherche en Cancérologie de Montpellier, Inserm U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France

J Nucl Med 2023; 64:1956–1964

 

Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy

David Kersting, Walter Jentzen, Daniel Jeromin, Ilektra-Antonia Mavroeidi, Maurizio Conti, Florian Büther, Ken Herrmann, Christoph Rischpler, Rainer Hamacher, Wolfgang P. Fendler, Robert Seifert, and Pedro Fragoso Costa

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany

J Nucl Med 2023; 64:329–336

 

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

David Kersting, Patrick Sandach, Miriam Sraieb, Marcel Wiesweg, Martin Metzenmacher, Kaid Darwiche, Filiz Oezkan, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Rainer Hamacher, Wolfgang P. Fendler, Johannes Wienker, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, and Hubertus Hautzel

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany

J Nucl Med 2023; 64:1540–1549

 

Longitudinal Tau PET Using 18F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters

Denise Visser, Hayel Tuncel, Rik Ossenkoppele, Maqsood Yaqub, Emma E. Wolters, Tessa Timmers, Emma Weltings, Emma M. Coomans, Marijke E. den Hollander, Wiesje M. van der Flier, Bart N.M. van Berckel, and Sandeep S.V. Golla

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands

J Nucl Med 2023; 64:281–286

 

Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden

Denise A. Gococo-Benore, Justin Kuhlman, Ephraim E. Parent, Akash Sharma, Joseph Accurso, Ming Yang, Ayse Tuba Kendi, Geoff Johnson, Mohamad Bassam Sonbol, Timothy Hobday, Thorvardur R. Halfdanarson, and Jason Starr

Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida

J Nucl Med 2023; 64:880–884

 

18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study

Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, Annouschka Laenen, Paul M. Clement, Karen Geboes, Eric Van Cutsem, Sigrid Stroobants, Chris Verslype, Guy Bormans, and Christophe M. Deroose

Nuclear Medicine, University Hospitals Leuven, and Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium

J Nucl Med 2023; 64:632–638

 

Lack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non–Small Cell Lung Cancer: Impact on Patient Outcomes

Emily Sterbis, Rifei Liang, Premal Trivedi, Jennifer Kwak, Erica Cohen Major, Sana D. Karam, and Rustain L. Morgan

Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado

J Nucl Med 2023; 64:75–81

 

A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum

Emma M. Coomans, Inge M.W. Verberk, Rik Ossenkoppele, Sander C.J. Verfaillie, Denise Visser, Mariam Gouda, Hayel Tuncel, Emma E. Wolters, Tessa Timmers, Albert D. Windhorst, Sandeep S.V. Golla, Philip Scheltens, Wiesje M. van, der Flier, Bart N.M. van Berckel, and Charlotte E. Teunissen

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands

J Nucl Med 2023; 64:437–443

 

Immuno-PET Detects Antibody–Drug Potency on Coadministration with Statins

Emma L. Brown, Shayla Shmuel, Komal Mandleywala, Sandeep Surendra Panikar, Na-Keysha Berry, Yi Rao, Abbey Zidel, Jason S. Lewis, and Patrícia M.R. Pereira

Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

J Nucl Med 2023; 64:1638–1646

 

Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy

Emma Mellhammar, Magnus Dahlbom, Oskar Vilhelmsson-Timmermand, and Sven-Erik Strand

Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

J Nucl Med 2023; 64:1632–1637

 

PET Imaging of Neutrophil Elastase with 11C-GW457427 in Acute Respiratory Distress Syndrome in Pigs

Emmi Puuvuori, Elena Chiodaroli, Sergio Estrada, Pierre Cheung, Norbert Lubenow, Jonathan Sigfridsson, Hampus Romelin, Sofie Ingvast, Mathias Elgland, Francesco Liggieri, Olle Korsgren, Gaetano Perchiazzi, Olof Eriksson, and Gunnar Antoni

Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden

J Nucl Med 2023; 64:423–429

 

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy

Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm, and Per Albertsson

Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

J Nucl Med 2023; 64:165–172

 

Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms

Esben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, and Andreas Kjaer

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2023; 64:252–259

 

Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease

Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend, and Nerissa T. Viola

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

J Nucl Med 2023; 64:1806–1814

 

Imaging Agents for PET of Inflammatory Bowel Disease: A Review

Farzaneh Rezazadeh, Aidan P. Kilcline, and Nerissa T. Viola

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

J Nucl Med 2023; 64:1858–1864

Prognostic Value of Tumor Volume Assessment on PSMA PET After 177Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0

Felix Kind, Ann-Christin Eder, Cordula A. Jilg, Philipp E. Hartrampf, Philipp T. Meyer, Juri Ruf, and Kerstin Michalski

Department of Nuclear Medicine, Medical Center, University of Freiburg, Freiburg, Germany

J Nucl Med 2023; 64:605–610

 

[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration

Ganna Blazhenets, David N. Soleimani-Meigooni, Wesley Thomas, Nidhi Mundada, Matthias Brendel, Stephanie Vento, Lawren VandeVrede, Hilary W. Heuer, Peter Ljubenkov, Julio C. Rojas, Miranda K. Chen, Alinda N. Amuiri, Zachary Miller, Maria L. Gorno-Tempini, Bruce L. Miller, Howie J. Rosen, Irene Litvan, Murray Grossman, Brad Boeve, Alexander Pantelyat, Maria Carmela Tartaglia, David J. Irwin, Brad C. Dickerson, Suzanne L. Baker, Adam L. Boxer, Gil D. Rabinovici, and Renaud La Joie

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California

J Nucl Med 2023; 64:1980–1989

 

Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis

Grayson Wass, Kari Clifford, and Rathan M. Subramaniam

Department of Medicine, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand

J Nucl Med 2023; 64:1218–1224

 

A Single-Arm, Low-Dose, Prospective Study of 177Lu-EB-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

Guochang Wang, Jie Zang, Yuanyuan Jiang, Qingxing Liu, Huimin Sui, Rongxi Wang, Xinrong Fan, Jingjing Zhang, Zhaohui Zhu, and Xiaoyuan Chen

Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

J Nucl Med 2023; 64:611–617

 

18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use

Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, and Christophe M. Deroose

Nuclear Medicine, University Hospitals Leuven, and Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University of Leuven, Leuven, Belgium

J Nucl Med 2023; 64:835–841

 

A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy

Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Guido A. Davidzon, Carina Mari Aparici, Christian Kunder, Geoffrey A. Sonn, and Andrei Iagaru

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California

J Nucl Med 2023; 64:592–597

 

A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer

Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Alan Thong, Christian Kunder, Carina Mari Aparici, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn, and Andrei Iagaru

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California

J Nucl Med 2023; 64:744–750

 

The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer

Hinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx, and Berlinda J. de Wit-van der Veen

Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands

J Nucl Med 2023; 64:63–68

 

Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma

Ines Maric, Manuel Weber, Andre Prochnow, Jochen Schmitz, Nicole Unger, Benedikt M. Schaarschmidt, Thorsten D. Poeppel, Christoph Rischpler, Andreas Bockisch, Ken Herrmann, Walter Jentzen, and Wolfgang P. Fendler

Department of Nuclear Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany

J Nucl Med 2023; 64:885–891

 

Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial

Ismaheel O. Lawal, Ashesh B. Jani, Omotayo A. Adediran, Subir Goyal, Olayinka A. Abiodun-Ojo, Vishal R. Dhere, Charles V. Marcus, Shreyas S. Joshi, Viraj A. Master, Pretesh R. Patel, Mark Goodman, Joseph W. Shelton, Omer Kucuk, Bruce Hershatter, Bridget Fielder, Raghuveer K. Halkar, and David M. Schuster

Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia

J Nucl Med 2023; 64:586–591

 

Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma

Jaehoon Shin, Matthew F.L. Parker, Iowis Zhu, Aryn Alanizi, Carlos I. Rodriguez, Raymond Liu, Payal B. Watchmaker, Mausam Kalita, Joseph Blecha, Justin Luu, Brian Wright, Suzanne E. Lapi, Robert R. Flavell, Hideho Okada, Thea D. Tlsty, Kole T. Roybal, and David M. Wilson

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California

J Nucl Med 2023; 64:137–144

 

The Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node–Negative Prostate Cancer Patients

Jan J. Duin, Hilda A. de Barros, Maarten L. Donswijk, Eva E. Schaake, Tim M. van der Sluis, Esther M.K. Wit, Fijs W.B. van Leeuwen, Pim J. van Leeuwen, and Henk G. van der Poel

Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

J Nucl Med 2023; 64:1563–1566

 

Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning

Janna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Häberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhäberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers, and Julian Kirchner

Department of Diagnostic and Interventional Radiology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany

J Nucl Med 2023; 64:304–311

 

Incidental Airway Findings on PET/CT with 18F-PSMA

Jason Orciuolo, Akash Sharma, Ephraim E. Parent, Joseph M. Accurso, Manoj K. Jain, and Jason R. Young

Liberty University College of Osteopathic Medicine, Lynchburg, Virginia

J Nucl Med 2023; 64:993

 

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE Treatment

Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, Katja Smits, Viktor Johanson, and Peter Bernhardt

Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden

J Nucl Med 2023; 64:1456-1462

 

Performance of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Evaluation of Erdheim–Chester Disease: A Comparison with 18F-FDG PET/CT

Jiangyu Ma, Qiao Yang, Li Huo, Jiawen Dai, Na Niu, and Xinxin Cao

Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

J Nucl Med 2023; 64:1385–1391

 

Left Ventricular Strain from Myocardial Perfusion PET Imaging: Method Development and Comparison to 2-Dimensional Echocardiography

Jingwen Huang, Adam J. Mitchell, Ernest V. Garcia, C. David Cooke, Russell Folks, Maria Pernetz, Abhinav Goyal, Marina Piccinelli, and Jonathon A. Nye

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

J Nucl Med 2023; 64:932–939

 

Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study

Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs, and Frank M. Bengel

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

J Nucl Med 2023; 64:1279–1286

 

Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid Carcinoma

Johanna S. Enke, Ralph A. Bundschuh, Georgine Wienand, Nic G. Reitsam, Malte Kircher, Christian H. Pfob, Constantin Lapa, and Alexander Dierks

Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany

J Nucl Med 2023; 64:2001

 

Importance of Blood Glucose Management Before 18F-FDG PET/CT in 322 Patients with Bacteremia of Unknown Origin

Jordy P. Pijl, Andor W.J.M. Glaudemans, Olivier Gheysens, Riemer H.J.A. Slart, and Thomas C. Kwee

Medical Imaging Center, Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2023; 64:1287–1294

 

[177Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement

Josefine Graef, Stephanie Bluemel, Winfried Brenner, Holger Amthauer, Peter Truckenmueller, David Kaul, Peter Vajkoczy, Julia S. Onken, and Christian Furth

Department of Nuclear Medicine, Charité–Universitätsmedizin Berlin, Berlin, Germany

J Nucl Med 2023; 64:892–895

 

Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy

Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M. Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe, and Guido Böning

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany

J Nucl Med 2023; 64:767–774

 

An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose

Julia Brosch-Lenz, Suqi Ke, Hao Wang, Eric Frey, Yuni K. Dewaraja, John Sunderland, and Carlos Uribe

Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada

J Nucl Med 2023; 64:1109–1116

 

Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy

Julie Bolcaen, Mohamed A. Gizawy, Samantha Y.A. Terry, António Paulo, Bart Cornelissen, Aruna Korde, Jonathan Engle, Valery Radchenko, and Roger W. Howell

SSC Laboratory, Radiation Biophysics, NRF iThemba LABS, Cape Town, South Africa

J Nucl Med 2023; 64:1344–1351

 

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer

Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug, and Marcus Hacker

Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria

J Nucl Med 2023; 64:1730–1736

 

Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher, and Wolfgang P. Fendler

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany

J Nucl Med 2023; 64:1049–1055

 

Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT

Lena Koller, Markus Joksch, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Nadine Holzleitner, Roswitha Beck, Gunhild von Amsberg, Hans-Jürgen Wester, Bernd Joachim Krause, and Thomas Günther

Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany

J Nucl Med 2023; 64:1654–1659

 

[68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis

Lena M. Unterrainer, Anthony E. Sisk, Johannes Czernin, Brian M. Shuch, Jeremie Calais. and Masatoshi Hotta

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

J Nucl Med 2023; 64:1660–1661

 

Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study

Letizia Calderoni, Elisa Maietti, Andrea Farolfi, Riccardo Mei, Karly S. Louie, Michael Groaning, and Stefano Fanti

Nuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Di S. Orsola, Bologna, Italy

J Nucl Med 2023; 64:910–917

 

Clinical Evaluation of 68Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin αvβ3 in Various Cancer Types

Liang Zhao, Xuejun Wen, Weizhi Xu, Yizhen Pang, Long Sun, Xiaoming Wu, Pengfei Xu, Jingjing Zhang, Zhide Guo, Qin Lin, Xiaoyuan Chen, and Haojun Chen

Department of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Center, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

J Nucl Med 2023; 64:1210–1217

Dosimetric Variability Across a Library of Computational Tumor Phantoms

Lukas M. Carter, Simone Krebs, Harry Marquis, Juan C. Ocampo Ramos, Edmond A. Olguin, Emilia O. Mason, Wesley E. Bolch, Pat B. Zanzonico, and Adam L. Kesner

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2023; 64:782–790

 

Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D’Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Weber, and Matthias Eiber

Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany

J Nucl Med 2023; 64:896–901

 

MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals

Lukas M. Carter, Juan C. Ocampo Ramos, Edmond A. Olguin, Justin L. Brown, Daniel Lafontaine, Derek W. Jokisch, Wesley E. Bolch, and Adam L. Kesner

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2023; 64:1295–1303

 

68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial

Lukas Kessler, Nader Hirmas, Kim M. Pabst, Rainer Hamacher, Justin Ferdinandus, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Michael Nader, Lale Umutlu, Waldemar Uhl, Anke Reinacher-Schick, Celine Lugnier, David Witte, Marco Niedergethmann, Ken Herrmann, Wolfgang P. Fendler, and Jens T. Siveke

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

J Nucl Med 2023; 64:1910–1917

 

Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)

Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns, and Roisin M. Connolly

Cancer Research @UCC, Cork, Ireland

J Nucl Med 2023; 64:1690–1696

 

Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers

Mahnoosh Naeimi, Peter L. Choyke, Katharina Dendl, Yuriko Mori, Fabian Staudinger, Tadashi Watabe, Stefan A. Koerber, Manuel Röhrich, Jürgen Debus, Clemens Kratochwil, Uwe Haberkorn, and Frederik L. Giesel

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

J Nucl Med 2023; 64:618–622

 

Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome

Manuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, Matthias Weissinger, Helmut Dittmann, Christian la Fougère, and Francesco Fiz

Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany

J Nucl Med 2023; 64:1431–1438

 

Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing 18F-FDG PET/CT with Conventional CT

Marianne Vogsen, Frederik Harbo, Nick M. Jakobsen, Henriette J. Nissen, Sara E. Dahlsgaard-Wallenius, Oke Gerke, Jeanette D. Jensen, Jon T. Asmussen, Anne Marie B. Jylling, Poul-Erik Braad, Werner Vach, Marianne Ewertz, and Malene G. Hildebrandt

Department of Oncology, Odense University Hospital, Odense, Denmark

J Nucl Med 2023; 64:355–361

 

The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer

Marinus J. Hagens, Wietske I. Luining, Auke Jager, Maarten L. Donswijk, Zing Cheung, Maurits Wondergem, Daniela E. Oprea-Lager, André N. Vis, Pim J. van Leeuwen, and Henk G. van der Poel

Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

J Nucl Med 2023; 64:1238-1243

 

Temporal Changes in Coronary 18F-Fluoride Plaque Uptake in Patients with Coronary Atherosclerosis

Marwa Daghem, Philip D. Adamson, Kang-Ling Wang, Mhairi Doris, Rong Bing, Edwin J.R. van Beek, Laura Forsyth, Michelle C. Williams, Evangelos Tzolos, Damini Dey, Piotr J. Slomka, Marc R. Dweck, David E. Newby, and Alastair J. Moss

British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

J Nucl Med 2023; 64:1478–1486

 

An Investigation of Lesion Detection Accuracy for Artificial Intelligence–Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms

Mathias Loft, Claes N. Ladefoged, Camilla B. Johnbeck, Esben A. Carlsen, Peter Oturai, Seppo W. Langer, Ulrich Knigge, Flemming L. Andersen, and Andreas Kjaer

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital–Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2023; 64:951–959

 

Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib

Meiqi Wu, Yanyu Wang, Qiao Yang, Xuezhu Wang, Xu Yang, Haiqun Xing, Xinting Sang, Xiang Li, Haitao Zhao, and Li Huo

Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

J Nucl Med 2023; 64:1532–1539

 

Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-l-Glutamate as System Formula–Targeting Radiopharmaceuticals

Milena Colovic, Hua Yang, Lily Southcott, Helen Merkens, Nadine Colpo, Francois Bénard, and Paul Schaffer

Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada

J Nucl Med 2023; 64:1314–1321

 

Imaging of Activated T Cells

Mohammad O. Sako and Benjamin M. Larimer

Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

J Nucl Med 2023; 64:30–33

 

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities

Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann, and Wolfgang P. Fendler

Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium (DKTK)–University Hospital Essen, Essen, Germany

J Nucl Med 2023; 64:711–716

 

Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases

Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins, and Michael C. Veronesi

School of Medicine, Indiana University, Indianapolis, Indiana

J Nucl Med 2023; 64:1087–1092

 

177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy

Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, William Counter, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Aron Poole, Adam Hickey, Shikha Agrawal, Gary Perkins, Annukka Kallinen, Enid Eslick, Martin R. Stockler, Anthony M. Joshua, Andrew Nguyen and Louise Emmett

Department of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia

J Nucl Med 2023; 64:410–415

 

First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma

Nils Florian Trautwein, Gerald Reischl, Christian Seitz, Helmut Dittmann, Ferdinand Seith, Sophia Scheuermann, Tobias Feuchtinger, Frank Dombrowski, Rupert Handgretinger, Jörg Fuchs, Bernd Pichler, Christian la Fougère, and Johannes Schwenck

Department of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, Tübingen, Germany

J Nucl Med 2023; 64:337–338

 

Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients

Noémie S. Minczeles, Wouter W. de Herder, Richard A. Feelders, Frederik A. Verburg, Johannes Hofland, and Tessa Brabander

Section of Endocrinology, Department of Internal Medicine, ENETS Centre of Excellence Rotterdam, Erasmus MC and Erasmus MC Cancer Centre, Rotterdam, The Netherlands

J Nucl Med 2023; 64:40–46

 

Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)

Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, Christel Fontaine, Denis Schallier, Sandrine Aspeslagh, Ilse Vaneycken, Geert Raes, Jo A. Van Ginderachter, Tony Lahoutte, Vicky Caveliers, and Marleen Keyaerts

MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium

J Nucl Med 2023; 64:1378–1384

 

Preclinical Evaluation of 89Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis

Olli Moisio, Jenni Virta, Emrah Yatkin, Heidi Liljenbäck, Senthil Palani, Riikka Viitanen, Maxwell W.G. Miner, Vesa Oikonen, Tuula Tolvanen, Danielle J. Vugts, Pekka Taimen, Xiang-Guo Li, Maija Hollmén, Sirpa Jalkanen, and Anne Roivainen

Turku PET Centre, University of Turku, Turku, Finland

J Nucl Med 2023; 64:555–560

 

Incidental Focal 68Ga-FAPI-46 Uptake in a Urachal Remnant: A Potential Pitfall Mimicking a Malignant Peritoneal Lesion

Peter George Maliha, Mahbod Jafarvard, Johannes Czernin, Jeremie Calais, and Masatoshi Hotta

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California

J Nucl Med 2023; 64:992

 

Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative

Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais, and Masatoshi Hotta

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

J Nucl Med 2023; 64:1839–1840

 

Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

Philipp E. Hartrampf, Patrick W. Mihatsch, Anna Katharina Seitz, Lilja B. Solnes, Steven P. Rowe, Martin G. Pomper, Hubert Kübler, Thorsten A. Bley, Andreas K. Buck, and Rudolf A. Werner

Department of Nuclear Medicine, University Hospital of Würzburg, Würzburg, Germany

J Nucl Med 2023; 64:1272–1278

Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab

Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers, and Charalampos Tsoumpas

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2023; 64:1815–1820

 

PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors

Qaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, Sideris Spyridon, Romain Diamand, Albert Santapau, Alexandre Peltier, Thierry Roumeguère, Patrick Flamen, and Carlos Artigas

Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium

J Nucl Med 2023; 64:1869–1875

 

Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer

Robert Seifert, Tugce Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann, and Wolfgang P. Fendler

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

J Nucl Med 2023; 64:738–743

 

Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis

Robert Seifert, Tugce Telli, Boris Hadaschik, Wolfgang P. Fendler, Phillip H. Kuo, and Ken Herrmann

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

J Nucl Med 2023; 64:731–737

 

Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET

Robin Gutsche, Carsten Lowis, Karl Ziemons, Martin Kocher, Garry Ceccon, Cláudia Régio Brambilla, Nadim J. Shah, Karl-Josef Langen, Norbert Galldiks, Fabian Isensee, and Philipp Lohmann

Institute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany

J Nucl Med 2023; 64:1594–1602

 

Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW

Ruben Y. Gabriëls, Lisanne E. van Heijst, Wouter T.R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas, and Wouter B. Nagengast

Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2023; 64:803–808

 

An Experimental Generator for Production of High-Purity 212Pb for Use in Radiopharmaceuticals

Ruth Gong Li, Vilde Yuli Stenberg and Roy Hartvig Larsen

Institute of Clinical Medicine, University of Oslo, Oslo, Norway

J Nucl Med 2023, 64:173–176

 

Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets

Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz, and Suzanne E. Lapi

Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

J Nucl Med 2023; 64:1791–1797

 

Molecular Imaging, Radiochemistry, and Environmental Pollutants

Samantha Delaney, Joni Sebastiano, Brian M. Zeglis, and Outi M. Keinänen

Department of Chemistry, Hunter College, City University of New York, New York, New York

J Nucl Med 2023; 64:1179–1184

 

Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors

Sandeep Surendra Panikar, Nai Keltee, Na-Keysha Berry, Shayla Shmuel, Zachary T. Fisher, Emma Brown, Abbey Zidel, Alex Mabry, and Patrícia M.R. Pereira

Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

J Nucl Med 2023; 64:1195–1202

 

Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study

Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo, and Chandrasekhar Bal

Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

J Nucl Med 2023; 64:211–218

 

The Prognostic Value of Posttreatment 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)

Sarennya Pathmanandavel, Megan Crumbaker, Andrew Nguyen, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Peter Eu, Andrew J. Martin, Martin R. Stockler, Anthony M. Joshua, and Louise Emmett

Department of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia

J Nucl Med 2023; 64:69–74

 

Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)

Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen, and Louise Emmett

Department of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia

J Nucl Med 2023; 64:221–226

 

Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis

Sebastian K. Chung, Daniela Burnes Vargas, Christopher S. Chandler, Sumudu Katugampola, Darren R. Veach, Michael R. McDevitt, Shin H. Seo, Brett A. Vaughn, Sara S. Rinne, Blesida Punzalan, Mitesh Patel, Hong Xu, Hong-Fen Guo, Pat B. Zanzonico, Sébastien Monette, Guangbin Yang, Ouathek Ouerfelli, Garrett M. Nash, Andrea Cercek, Edward K. Fung, Roger W. Howell, Steven M. Larson, Sarah M. Cheal, and Nai-Kong V. Cheung

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2023; 64:1439–1445

 

The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to 177Lu-Prostate-Specific Membrane Antigen Therapy

Shejil Kumar, Megan Crumbaker, Christopher Harvey, Sarennya Pathmanandavel, Nikieth John, Mina M. Swiha, Michelle M. McDonald, Roderick Clifton-Bligh, Adrian Lee, Patricia Bastick, William Counter, Andrew Nguyen, and Louise Emmett

Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia

J Nucl Med 2023; 64:1412–1416

 

Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression

Simon Isser, Andreas Maurer, Gerald Reischl, Martin Schaller, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Meinrad Gawaz, Bernd J. Pichler, and Nicolas Beziere

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University of Tübingen, Tübingen, Germany

J Nucl Med 2023; 64:940–945

 

Fibroblast Activation Protein–Targeted Radioligand Therapy for Treatment of Solid Tumors

Spencer D. Lindeman, Ramesh Mukkamala, Autumn Horner, Pooja Tudi, Owen C. Booth, Roxanne Huff, Joshua Hinsey, Anders Hovstadius, Peter Martone, Fenghua Zhang, Madduri Srinivasarao, Abigail Cox, and Philip S. Low

Department of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana

J Nucl Med 2023; 64:759–766

 

Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET

Spenser R. Simpson, Alexandria E. Kesterson, Justin H. Wilde, Zoraiz Qureshi, Bijoy Kundu, Mark P. Simons, and Kiel D. Neumann

Department of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, Tennessee

J Nucl Med 2023; 64:809–815

 

Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET

Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke, and Freddy E. Escorcia

Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

J Nucl Med 2023; 64:1017–1023

 

[177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis

Swayamjeet Satapathy, Ranjit K. Sahoo, and Chandrasekhar Bal

Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

J Nucl Med 2023; 64:1266–1271

 

[177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial

Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla, and Shrawan Kumar Singh

Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

J Nucl Med 2023; 64:1726–1729

 

Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans

Taymeyah Al-Toubah, Jaime Montilla-Soler, Ghassan El-Haddad, Mintallah Haider, and Jonathan Strosberg

Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

J Nucl Med 2023; 64:1895–1898

 

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Cleo Goyvaerts, Kim De Veirman, Alfred Morgenstern, Frank Bruchertseifer, Marleen Keyaerts, Nick Devoogdt, Matthias D’Huyvetter, and Karine Breckpot

Department of Biomedical Sciences, Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium

J Nucl Med 2023; 64:751–758

 

18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models

Thuc M. Le, Hailey R. Lee, Evan R. Abt, Khalid Rashid, Amanda L. Creech, Keke Liang, Jing Cui, Arthur Cho, Liu Wei, Amanda Labora, Charlotte Chan, Eric Sanchez, Kriti Kriti, Daniel Karin, Luyi Li, Nanping Wu, Christine Mona, Giuseppe Carlucci, Willy Hugo, Ting-Ting Wu, Timothy R. Donahue, Johannes Czernin, and Caius G. Radu

Molecular and Medical Pharmacology, UCLA, Los Angeles, California

J Nucl Med 2023; 64:117–123

 

Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer

Tim E. Phelps, Stephanie A. Harmon, Esther Mena, Liza Lindenberg, Joanna H. Shih, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke, and Baris Turkbey

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

J Nucl Med 2023; 64:395-401

 

Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis

Timo Schlürmann, Birgit Waschulzik, Stephanie Combs, Jens Gempt, Benedikt Wiestler, Wolfgang Weber, and Igor Yakushev

Department of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

J Nucl Med 2023; 64:816–821

 

Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls

Tristan T. Demmert, Ines Maric, Kelsey L. Pomykala, Katharina Lueckerath, Jens Siveke, Benedikt M. Schaarschmidt, Rainer Hamacher, Ken Herrmann, and Wolfgang P. Fendler

Department of Nuclear Medicine, West German Cancer Center, University of Duisburg–Essen, Essen, Germany

J Nucl Med 2023; 64:368–371

 

Oncologic Staging with 68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET/CT

Tristan T. Demmert, Kelsey L. Pomykala, Helena Lanzafame, Kim M. Pabst, Katharina Lueckerath, Jens Siveke, Lale Umutlu, Hubertus Hautzel, Rainer Hamacher, Ken Herrmann, and Wolfgang P. Fendler

Department of Nuclear Medicine, West German Cancer Center, University of Duisburg-Essen, Essen, Germany

J Nucl Med 2023; 64:1906–1909

Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine

Tudor M. Ionescu, Mario Amend, Tadashi Watabe, Jun Hatazawa, Andreas Maurer, Gerald Reischl, Bernd J. Pichler, Hans F. Wehrl, and Kristina Herfert

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Tuebingen, Germany

J Nucl Med 2023; 64:466–471

 

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer

Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmüller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Shahrokh Shariat, Gerda Egger, and Markus Zeitlinger

Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria

J Nucl Med 2023; 64:863–868

 

Pretargeting with Cucurbituril–Adamantane Host–Guest Pair in Xenograft Models

Vilma I.J. Jallinoja, Courtney H. Abbriano, Kavita Bhatt, Amritjyot Kaur, David J. Schlyer, Paul J. Yazaki, Brandon D. Carney, and Jacob L. Houghton

Department of Radiology, Stony Brook University, Stony Brook, New York

J Nucl Med 2023; 64:1203–1209

 

PSMA-Negative Lesion Progression Under 177Lu-PSMA Radioligand Therapy

Vishnu Murthy, Martin Allen-Auerbach, Richard Lam, Dawn Owen, Johannes Czernin, and Jeremie Calais

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California

J Nucl Med 2023; 64:1502-1503

 

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis

Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin, and Jeremie Calais

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California

J Nucl Med 2023; 64:1737–1743

 

Albumin-Binding and Conventional PSMA Ligands in Combination with 161Tb: Biodistribution, Dosimetry, and Preclinical Therapy

Viviane J. Tschan, Sarah D. Busslinger, Peter Bernhardt, Pascal V. Grundler, Jan Rijn Zeevaart, Ulli Köster, Nicholas P. van der Meulen, Roger Schibli, and Cristina Müller

Center for Radiopharmaceutical Sciences ETH–PSI, Paul Scherrer Institute, Villigen-PSI, Switzerland

J Nucl Med 2023; 64:1625–1631

 

Response Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy

Xinying Hu, Tao Zhou, Jiazhong Ren, Jinghao Duan, Hongbo Wu, Xiaoli Liu, Zhengshuai Mu, Ning Liu, Yuchun Wei, and Shuanghu Yuan

Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China

J Nucl Med 2023; 64:625–631

 

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT

Xuetao Chen, Shuailiang Wang, Yumei Lai, Guochang Wang, Maomao Wei, Xiao Jin, Jin Ding, Yan Zhang, Yunfei Shi, Feng Wang, Hua Zhu, Zhi Yang, and Xuejuan Wang

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Medical Products Association, Key Laboratory for Research and Evaluation of Radiopharmaceuticals, National Medical Products Association, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China

J Nucl Med 2023; 64:1399–1405

 

High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections

Yiran Wang, Benjamin A. Spencer, Jeffrey Schmall, Elizabeth Li, Ramsey D. Badawi, Terry Jones, Simon R. Cherry, and Guobao Wang

Department of Radiology, University of California Davis Medical Center, Sacramento, California

J Nucl Med 2023; 64:1154–1161

 

Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery

Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang

Department of Radiology, Davis Medical Center, University of California, Sacramento, California

J Nucl Med 2023; 64:1821–1830

 

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis

Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin, and Jeremie Calais

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California

J Nucl Med 2023; 64:1737–1743

 

PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study

Yizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Long Sun, and Haojun Chen

Department of Nuclear Medicine and Minnan PET Center, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

J Nucl Med 2023; 64:386–394

 

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy

Yizhen Pang, Liang Zhao, Jianyang Fang, Jianhao Chen, Lingxin Meng, Long Sun, Hua Wu, Zhide Guo, Qin Lin, and Haojun Chen

Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

J Nucl Med 2023; 64:1449–1455

 

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment

Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan, and Michael R. Zalutsky

Department of Radiology, Duke University Medical Center, Durham, North Carolina

J Nucl Med 2023; 64:124–130

 

ERF SNMMI JNM Best Paper Awards

The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE BEST CLINICAL ARTICLE IN 2023

is presented to

Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs, and Frank M. Bengel

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

for

Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study

J Nucl Med. 2023; 64:1279–1286

The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE BEST BASIC SCIENCE ARTICLE IN 2023

is presented to

Spencer D. Lindeman, Ramesh Mukkamala, Autumn Horner, Pooja Tudi, Owen C. Booth, Roxanne Huff, Joshua Hinsey, Anders Hovstadius, Peter Martone, Fenghua Zhang, Madduri Srinivasarao, Abigail Cox, and Philip S. Low

Department of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana

for

Fibroblast Activation Protein–Targeted Radioligand Therapy for Treatment of Solid Tumors

J Nucl Med. 2023; 64:759–766

The Journal of Nuclear Medicine
Editors’ Choice Award
FOR THE OVERALL BEST ARTICLE IN 2023

is presented to

Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs, and Frank M. Bengel

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

for

Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study

J Nucl Med. 2023; 64:1279–1286

ERF-SNMMI-TS JNMT Best Paper Awards

Susan C. Weiss Clinical Advancement Scholarship

ERF-SNMMI-TS Bachelor's or Master's Degree Completion Scholarship - Brianna Reidel

ERF-SNMMI-TS Advanced Degree ScholarshipKeexia Osborne, CNMT

Paul Cole Student Technologist Scholarship - Hannah Ballard, Jaden Bardens, Caleb Cook, Erin Gibson, Katelyn LaLonde, Jonika Lattimore-Houston, Natalie Maufort, Mason Rogers, Katharine Sturgeon, Gary Suzuki, Young Thornton